|
It can be administered by a nasal spray. |
Fluticasone furoate
|
|
4.38 min. | 0 user rating |
Theravance, GlaxoSmithKline achieve mixed results from Relovair phase 3 studies - Proactive Investors USA & Canada Proactive Investors USA & Canada--Patients received either a once-daily, 100/25 microgram (mcg) dose of Relovair, which is comprised of -fluticasone furoate- and vilanterol (FFVI), an inhaled corticosteroid, or a twice-daily 250/50 mcg dose of Advair, - Date : Fri, 23 Mar 2012 19:23:08 GMT |
GlaxoSmithKline ups stake in COPD drug partner Theravance - The Pharma Letter The Pharma Letter--The news follows the recent announcement that the registrational program for their investigational drug Relovair (-fluticasone furoate- and vilanterol (FF/VI) is now complete (The Pharma Letter March 26). For chronic obstructive pulmona - Date : Tue, 03 Apr 2012 09:22:48 GMT |
Canadian Generic Pharmaceutical Association v. Canada (Minister of Health) and ... - Lexology (registration) Lexology (registration)--This appeal affirmed two lower decisions (2011 FC 465 and 2010 FC 1211) where it was held that the CGPA lacked standing to bring the application to dispute the listing of -fluticasone furoate- on the Patent Register on the basis t - Date : Tue, 24 Jan 2012 10:18:18 GMT |
Glaxo and Theravance Suffer Setback - Zacks.com Zacks.com--Relovair is a combination of -fluticasone furoate- and vilanterol. In the two COPD studies, Relovair reduced the annual rate of moderate-to-severe exacerbations (worsening of severity of disease) compared to vilanterol. However, in the second s - Date : Thu, 12 Jan 2012 22:16:23 GMT |
Morning Movers 01/09: (INHX) (IDIX) (SMSI) (CVV) (VVUS) Higher; (THRX) (IPCM ... - StreetInsider.com (subscription) StreetInsider.com (subscription)--Theravance, Inc. (Nasdaq: THRX) 31.7% LOWER; GlaxoSmithKline (NYSE: GSK) and Theravance today announced the completion of the phase III registration programme for the once-daily investigational medicine Relovair" - Date : Mon, 09 Jan 2012 16:21:04 GMT |
GlaxoSmithKline завершила испытания III фазы по препарату Relovair - Азиатский репортер Азиатский репортер--GlaxoSmithKline PLC и Theravance Inc. объявили в понедельник о завершении испытаний III фазы препарата Relovair (-fluticasone furoate-/vilanterol), в ходе ко - Date : Mon, 09 Jan 2012 09:52:39 GMT |
复方Relovair治疗COPD III期研究结果积极 - 生物谷 生物谷--Relovair为一日一次的吸入型皮质类固醇(ICS)和长效β2-受体激动剂(LABA)的复方治疗药物(FF/VI),即糠酸氟替卡松(-Fluticasone Furoate-,FF)和维兰特罗(Vilanterol,VI),目前该药正处� - Date : Wed, 08 Jun 2011 02:57:03 GMT+00:00 |
GlaxoSmithKline Reports Results Of Phase III Studies Of Relovair - Wall Street Journal Wall Street Journal---Relovair is a once-daily inhaled corticosteroid (ICS)/long-acting beta-agonist (LABA) combination treatment, comprising -fluticasone furoate- and vilanterol (FF/VI), currently under development for the treatment of COPD and asthma. . - Date : Thu, 02 Jun 2011 11:31:27 GMT+00:00 |
Glaxo's asthma market lead to run out of puff - Australian Life Scientist Australian Life Scientist--Later this year Glaxo is expected to launch in Australia its new once-daily Relovair (-fluticasone furoate-/vilanterol) asthma treatment product. ... - Date : Mon, 24 May 2010 21:59:21 GMT+00:00 |
Topical | ||
---|---|---|
Sympathomimetics, plain | Cyclopentamine * Ephedrine * Phenylephrine * Oxymetazoline * Tetryzoline * Xylometazoline * Naphazoline * Tramazoline * Metizoline * Tuaminoheptane * Fenoxazoline * Tymazoline * Epinephrine | |
Antiallergic agents, excluding corticosteroids | Spaglumic acid histamine antagonists (Levocabastine, Antazoline, Thonzylamine) mast cell stabilizer (some are also antihistamines) (Cromoglicic acid, Nedocromil, Azelastine, Olopatadine, Lodoxamide) | |
Corticosteroids | Beclometasone * Prednisolone * Dexamethasone * Flunisolide * Budesonide * Betamethasone * Tixocortol * Fluticasone * Mometasone furoate * Triamcinolone * Ciclesonide | |
Other nasal preparations | Cafaminol * Calcium hexamine thiocyanate * Retinol * Ipratropium bromide * Ritiometan * Mupirocin * Hexamidine * Framycetin * Hyaluronic acid * Eucalyptus oil | |
Systemic use: Sympathomimetics | ||
Phenylpropanolamine * Pseudoephedrine * Phenylephrine * Phenylpropylamine |belowstyle=background:MistyRose |